skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Real-time tracking and analysis of the drug development pipeline

Biomedtracker | Pharma intelligence

Track and understand the impacts of market events for the companies, diseases, products, and targets you care about. Leverage reliable real-time data, analyst insights, and proprietary likelihood of approval analytics to predict and successfully navigate what lies ahead.

How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.

How it works
Our data and analysts insights cut through the noise, so you not only know what happens, but understand why it matters for your business. Biomedtracker provides analysis of commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface and automated alerts that keeps you at the top of your game.

What's included

Pharma Intelligence: latest

  • Biomedtracker, Datamonitor Healthcare

    Key Potential Drug Launches in 2022

    23 Sep 2021

    Key Potential Drug Launches in 2022

    Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

  • Biomedtracker, Datamonitor Healthcare

    2020 Deal-Making Roundup

    21 Sep 2021

    2020 Deal-Making Roundup

    Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

    Topic Drug Review Coronavirus

  • Biomedtracker, Meddevicetracker

    Q3 2021 Outlook Report

    27 Aug 2021

    Q3 2021 Outlook Report

    What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

    Topic Drug Review

  • Datamonitor Healthcare, Biomedtracker, Scrip

    2021 Post-ASCO Insights and Analysis

    11 Aug 2021

    post-asco-2021

    The American Society of Clinical Oncology (ASCO) hosted its annual meeting from June 4-8 2021 and our team has the exclusive insights and analysis you can access today.

    Topic Cancer

  • Citeline, Biomedtracker, Pharma Consulting, Datamonitor Heal...

    COVID-19 24 hour webinar recordings

    30 Apr 2021

    Catch up on any missed COVID-19 24 hour webinar sessions

    Topic Cardiovascular Coronavirus

  • Biomedtracker

    Biopharma Partnering and Financing Trends, H1 2020 Whitepaper

    By Patricia Giglio 08 Apr 2021

    Biopharma Partnering and Financing Trends, H1 2020 Whitepaper

    Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry

    Topic BIO-Europe

  • Biomedtracker, Scrip

    39th Annual J.P. Morgan Healthcare Conference 2021

    19 Mar 2021

    39th Annual J.P. Morgan Healthcare Conference 2021

    Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

  • Biomedtracker

    2021 Clinical Development Success Rates

    03 Mar 2021

    2021 Clinical Development Success Rates

    This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

    Topic Clinical Trials Drug Development Landscape Drug Pricing

  • Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...

    COVID-19 Infographic

    27 Nov 2020

    COVID-19 Infographic

    Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

    Topic Coronavirus

  • Datamonitor Healthcare, Biomedtracker

    COVID-19 and the impact on the clinical trial space

    By Dustin Phan 27 Nov 2020

    COVID-19 and the impact on the clinical trial space

    The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

    Topic Coronavirus Clinical Trials

  • Biomedtracker

    A Historic Decade of Deal Making

    27 Nov 2020

    A Historic Decade of Deal Making

    In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.

    Topic M A

  • Biomedtracker

    A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

    By Daniel Chancellor 27 Nov 2020

    A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

    Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

    Topic M A

  • Biomedtracker, Meddevicetracker

    Q4 Outlook Report 2020

    17 Nov 2020

    q4 Outlook report

    The world-class data contained in this report extract will keep you up to speed on the drug development landscape for better decision-making

  • Biomedtracker, Datamonitor Healthcare

    Key Potential Drug Launches in 2021

    06 Oct 2020

    Key Potential Drug Launches 2021

    Valuable insight and expert analyst commentary 2021’s expected drug launches, their indications, commercial potential, regulatory catalysts and more.

  • Pharmaprojects, Biomedtracker

    The Race to Find a COVID-19 Treatment - Infographic

    29 Apr 2020

    The Race to Find a COVID-19 Treatment - Infographic

    Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

    Topic Coronavirus FDA Drug Review

Meet the team

Management

Gail Parziale

Management, ​Head of Intelligence Editorial Operations
Gail Parziale

Gail specializes in

  • Commercial Strategy
  • Clinical Trials

24+ years of experience

Analyst

Rachel Meighan-Mantha

Analyst, Principal Analyst

USA

Rachel Meighan-Mantha

Rachel specializes in

  • Oncology
  • Clinical Trials

24+ years of experience

Analyst

David Dahan

Analyst, Scientific Analyst

San Diego, USA

David Dahan

David specializes in

  • Infectious Diseases
  • Clinical Trials

23+ years of experience

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: